Intermittent Explosive Disorder and Chronic Inflammation

Displays of aggressive outbursts portray a mental illness known as the Intermittent Explosive Disorder. This disorder, unfortunately, is also believed to be linked with inflammation, according to a blood test analysis by researchers.

Inflammation is the term used to describe the body’s effort to keep it safe from the attacks of pathogens. When body is threatened, it reacts by inflating the particular body part, and begins the healing process.’ [You can find out more about inflammation at http://benthamsciencepublishers.blogspot.com/2013/12/inflammation-innate-immune-system.html

In fact, according to a study by Dr. Stephen H Boyle of Duke University Medical Center in Durham, North Carolina, recurring outbursts of anger might have a biological basis. People who have been diagnosed with this condition suffer repeated episodes of aggressive behavior.  They often lose control over trivial things and react with violent outbursts, like hurting people physically, throwing things around and vandalizing property.

Researchers and scientists advocate that increased levels of C-reactive protein and Interleukin-6 are indicators of possible inflammation in blood. These two are also believed to have strong connection with impulsive and aggressive behavior in people. There is a cause and effect relationship between inflammation and IED.

A number of methods are available for the treatment of Intermittent Explosive Disorder or IED, such as medication and behavioral therapy. Seeking treatment is important for the patient as opposed to keeping up with their hostile treatment of family and friends. Moreover, inflammation also put people at risk for other medical complications such as heart attack, arthritis and stroke.

One of the latest additions in the field is “Inflammation & Allergy - Drug Targets”, a popular research journal published by one of the leading STM publishers in the industry, Bentham Science Publishers. The journal aims to cater to the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continues to grow, this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.